The inventor of the groundbreaking Crispr gene-editing technology is skeptical about artificial intelligence replacing human ...
Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Eli Lilly struck a deal Tuesday to develop ...
In 2026, the biotech landscape has undergone a seismic shift, moving beyond the hype cycles of the past decade into a phase of tangible, life-saving applications. With the first wave of CRISPR-based ...
Gene editing, a set of techniques used to alter sections of an organism's DNA, is helping scientists cure diseases previously considered untreatable. That's why biotechs that specialize in gene ...
10don MSN
Quantum-inspired AI could tailor patients' cancer treatment to their entire molecular background
For a child diagnosed with neuroblastoma—the most common infant cancer, occurring when early nerve cells grow out of ...
BOSTON — In a potentially significant advance for the genome editing field, researchers from the biotechnology company Caszyme and the Vilnius University Institute of Biotechnology in Lithuania have ...
Cardiovascular diseases could be among the world’s first medical conditions to be treated by changing a patient’s genes. If ongoing phase 3 trials succeed, gene editing will offer a novel therapy for ...
The 2026 Warren Alpert Foundation Prize has been awarded to five scientists for their work leading to curative genetic ...
Well before the term “personalized medicine” first appeared, the notion of healthcare tailored to the individual loomed on ...
CRISPR Therapeutics' gene-editing platform looks fairly promising, but plenty of challenges could sink the stock. Vertex Pharmaceuticals has a robust underlying business along with some exposure to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results